Balanced Pharma Incorporated (BPI) announced Tuesday its acquisition of rights to Enduracaine Dental, a new non-opioid injectable pain relief drug intended for post-surgical use in
The post Balanced Pharma secures rights to new non-opioid pain relief drug for global dental market appeared first on Oral Health Group.